This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Dopamine HCl (2014-09-17)

Starting date:
September 17, 2014
Posting date:
September 29, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-41583

Recalled products

  1. Dopamine HCl

Reason

Firm identified that a small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the over pouch.

Depth of distribution

Wholesaler,hospitals (Quebec, Nova Scotia, New Brunswick)

Affected products

A. Dopamine HCl

DIN, NPN, DIN-HIM
DIN 00761850
Dosage form
  • Solution
Strength
  • Dextrose 50 mg/mL
  • Dopamine Hydrochloride 0.8 mg/mL
Lot or serial number
  • P303172
Companies
Recalling Firm
Baxter Corporation
7125 Mississauga Rd.
Mississauga
L5N 0C2
Ontario
CANADA
Marketing Authorization Holder
Baxter Corporation
7125 Mississauga Rd.
Mississauga
L5N 0C2
Ontario
CANADA

Date modified: